Search Results - "Burton, Jack D."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy by BURTON, Jack D, ELY, Scott, REDDY, Praveen K, STEIN, Rhona, GOLD, David V, CARDILLO, Thomas M, GOLDENBERG, David M

    Published in Clinical cancer research (01-10-2004)
    “…Purpose: CD74 (HLA-DR-associated invariant chain) plays a role in antigen presentation. In addition to its expression on antigen-presenting cells, it is…”
    Get full text
    Journal Article
  2. 2

    Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types by Burton, Jack D., Goldenberg, David M., Blumenthal, Rosalyn D.

    Published in PPAR Research (01-01-2008)
    “…PPARγ is a therapeutic target that has been exploited for treatment of type II diabetes mellitus (T2DM) with agonist drugs. Since PPARγ is expressed by many…”
    Get full text
    Journal Article
  3. 3

    The MTT assay to evaluate chemosensitivity by Burton, Jack D

    Published in Methods in molecular medicine (2005)
    “…The assessment of the degree or rate of cellular proliferation and cell viability is critical to the assessment of the effects of drugs, antibodies, or…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Peroxisome proliferator-activated receptor-γ antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines by Burton, Jack D, Castillo, Mary E, Goldenberg, David M, Blumenthal, Rosalyn D

    Published in Anti-cancer drugs (01-06-2007)
    “…Peroxisome proliferator-activated receptor-γ ligands have preclinical and clinical anticancer activity. Most studies in this area address agonists, with…”
    Get full text
    Journal Article
  6. 6

    New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma by Burton, Jack D, Goldenberg, David M

    Published in Expert opinion on emerging drugs (01-12-2010)
    “…B-cell non-Hodgkin lymphoma (NHL) is a significant public health problem as the most common hematologic malignancy in many areas of the world. Current…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies by TENDLER, C. L, BURTON, J. D, JAFFE, J, DANIELPOUR, D, CHARLEY, M, MCCOY, J. P, PITTELKOW, M. R, WALDMANN, T. A

    Published in Cancer research (Chicago, Ill.) (15-08-1994)
    “…The Sézary syndrome (SzS) and adult T-cell leukemia (ATL) are malignant proliferations of mature T-lymphocytes that possess distinct functions. Sézary cells…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells by Tagaya, Y., Burton, J. D., Miyamoto, Y., Waldmann, T. A.

    Published in The EMBO journal (16-09-1996)
    “…Interleukin‐15/T(IL‐15) is a growth factor that utilizes IL‐2 receptor (IL‐2R) components in addition to its private binding protein IL‐15R(alpha) in T‐cells…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis by Tendler, C L, Greenberg, S J, Burton, J D, Danielpour, D, Kim, S J, Blattner, W A, Manns, A, Waldmann, T A

    Published in Journal of cellular biochemistry (01-08-1991)
    “…The human T-cell lymphotropic virus type I (HTLV-I) is capable of inducing a variety of host cellular genes including many of the cytokines responsible for…”
    Get more information
    Journal Article
  16. 16

    The interleukin (IL) 2 receptor (beta) chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells by Bamford, Richard N, Grant, Angus J, Burton, Jack D, Peters, Christian

    “…It is shown that the interleukin-T-mediated stimulation of cytokine-dependent T-cell line or the activation of large granular lymphocytes is not blocked by the…”
    Get full text
    Journal Article
  17. 17

    Malignant chronic lymphocytic leukemia B cells elaborate soluble factors that down-regulate T cell and NK function by Burton, J D, Weitz, C H, Kay, N E

    Published in American journal of hematology (01-02-1989)
    “…To determine if the frequently observed T cell and natural killer dysfunction in B-chronic lymphocytic leukemia might be related to the presence of large…”
    Get more information
    Journal Article
  18. 18

    Human B lymphocytes express the p75 component of the interleukin 2 receptor by Begley, C G, Burton, J D, Tsudo, M, Brownstein, B H, Ambrus, Jr, J L, Waldmann, T A

    Published in Leukemia research (1990)
    “…The nature of the interleukin 2 (IL-2) receptor on purified human B lymphocytes was examined. Both normal and malignant cells showed evidence of a 70-75,000…”
    Get more information
    Journal Article